[
1. Williams DM. Clinical Pharmacology of Corticosteroids. Respir Care. 2018;63(6):655-670.10.4187/respcare.0631429794202
]Search in Google Scholar
[
2. Alan IS, Alan B. Side Effects of Glucocorticoids. In: Malangu N, editor. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. London: IntechOpen; 2017. p. 93-124.10.5772/intechopen.72019
]Search in Google Scholar
[
3. Stanbury RM, Graham EM. Systemic corticosteroid therapy-side effects and their management. Br J Ophthalmol. 1998;82(6):704-8.10.1136/bjo.82.6.70417226229797677
]Search in Google Scholar
[
4. Hougardy DM, Peterson GM, Bleasel MD, Randall CT. Is enough attention being given to the adverse effects of corticosteroid therapy. Journal of Clinical Pharmacy and Therapeutics. 2000;25(3):227-234.10.1046/j.1365-2710.2000.00284.x10886467
]Search in Google Scholar
[
5. McDougall D, Bhibhatbhan A, Toth C. Adverse effects of corticosteroid therapy in neuromuscular diseased patients are common and receive insufficient prophylaxis. Acta Neurol Scand. 2009;120(5):364-7.10.1111/j.1600-0404.2009.01190.x19832774
]Search in Google Scholar
[
6. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14(1):2029-2049.10.2147/TCRM.S138000622590730464484
]Search in Google Scholar
[
7. Rees A, Levy M, Lansdown A. Clinical endocrinology and diabetes at a glance. 1st ed. Hoboken: Wiley; 2017.
]Search in Google Scholar
[
8. Compston J. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7-16.10.1007/s12020-018-1588-2599711629691807
]Search in Google Scholar
[
9. Sheu A, Diamond T. Bone mineral density: testing for osteoporosis. Australian prescriber. 2016;39(2):35-39.10.18773/austprescr.2016.020491763527340320
]Search in Google Scholar
[
10. WHO Scientific Group on the assessment of osteoporosis at primary health care level. Summary meeting report. Brussels: World Health Organization.; 2004. p.1-17.
]Search in Google Scholar
[
11. Tu KN, Lie JD, Wan CKV, Cameron M, Austel AG, Nguyen JK, Van K, Hyun D. Osteoporosis: A Review of Treatment Options. P T. 2018;43(2):92-104.
]Search in Google Scholar
[
12. Peng YL, Hu HY, Luo JC, Hou MC, Lin HC, Lee FY. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study. Osteoporos Int. 2014;25(5):1617-23.10.1007/s00198-014-2647-z24566586
]Search in Google Scholar
[
13. Lindsay R, Krege JH, Marin F, Jin L, Stepan JJ. Teriparatide for osteoporosis: importance of the full course. Osteoporos Int. 2016;27(8):2395-410.10.1007/s00198-016-3534-6494711526902094
]Search in Google Scholar
[
14. Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357(20):2028-39.10.1056/NEJMoa071408
]Search in Google Scholar
[
15. Joseph RM, Hunter AL, Ray DW, Dixon WG. Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review. Semin Arthritis Rheum. 2016;46(1):133-41.10.1016/j.semarthrit.2016.03.001
]Search in Google Scholar
[
16. Ospina NS, Al Nofal A, Bancos I, Javed A, Benkhadra K, Kapoor E, Lteif AN, Natt N, Murad MH. ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2016 Fe;101(2):427-34.10.1210/jc.2015-1700
]Search in Google Scholar
[
17. Morris D. Steroid-induced diabetes and hyperglycaemia. Part 1: mechanisms and risks. Diabetes & Primary Care. 2018;20(4):151-3.
]Search in Google Scholar
[
18. Ginzler EM, Aranow C. 7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus. Baillière’s Clinical Rheumatology. 1998;12(3):495-510.10.1016/S0950-3579(98)80032-0
]Search in Google Scholar
[
19. Satyanarayanasetty D, Pawar K, Nadig P, Haran A. Multiple Adverse Effects of Systemic Corticosteroids: A Case Report. J Clin Diagn Res. 2015;9(5):FD01-2.
]Search in Google Scholar
[
20. Khurshid HF, Zikria S, Hamid S, Kumar VA. Self-Medication of Corticosteroids: A Life Threatening Case Report from Pakistan. Journal of Pharmacy Practice and Community Medicine. 2016;2(3):96-9.10.5530/jppcm.2016.3.7
]Search in Google Scholar